Breast cancer mortality rates among United States (US) women aged 30-79 years between 1975 and 2019.
Mersana slapped with partial FDA hold after five patient deaths in ovarian cancer studies
Another one of Mersana’s clinical programs is reporting patient deaths in a study, and now it’s prompting the FDA to step in. The agency slapped